Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2004-9-3
pubmed:abstractText
1. The aim of this study was to analyse the effects of eliprodil, a noncardiac drug with neuroprotective properties, on the cardiac repolarisation under in vitro circumstances, under normal conditions and after the attenuation of the 'repolarisation reserve' by blocking the inward rectifier potassium current (I(K1)) current with BaCl(2). 2. In canine right ventricular papillary muscle by applying the conventional microelectrode technique, under normal conditions, eliprodil (1 microm) produced a moderate reverse rate-dependent prolongation of the action potential duration (7.4+/-1.5, 8.9+/-2.1 and 9.9+/-1.8% at cycle lengths of 300, 1000 and 5000 ms, respectively; n=9). 3. This effect was augmented in preparations where I(K1) was previously blocked by BaCl(2) (10 microm). BaCl(2) alone lengthened APD in a reverse frequency-dependent manner (7.0+/-1.3, 14.2+/-1.6 and 28.1+/-2.1% at cycle lengths of 300, 1000 and 5000 ms, respectively; n=8). When eliprodil (1 microm) was administered to these preparations, the drug induced a marked further lengthening relative to the APD values measured after the administration of BaCl(2) (12.5+/-1.0, 17.6+/-1.5 and 20.5+/-0.9% at cycle lengths of 300, 1000 and 5000 ms, respectively; n=8). 4. In the normal Langendorff-perfused rabbit heart, eliprodil (1 microm) produced a significant QT(c) prolongation at 1 Hz stimulation frequency (12.7+/-1.8%, n=9). After the attenuation of the 'repolarisation reserve' by the I(K1) blocker BaCl(2) (10 microm), the eliprodil-evoked QT(c) prolongation was greatly enhanced (28.5+/-7.9%, n=6). In two out of six Langendorff preparations, this QT(c) lengthening degenerated into torsade de pointes ventricular tachycardia. 5. Eliprodil significantly decreased the amplitude of rapid component of the delayed rectifier potassium current (I(Kr)), but slow component (I(Ks)), transient outward current (I(to)) and I(K1) were not considerably affected by the drug when measured in dog ventricular myocytes by applying the whole-cell configuration of the patch-clamp technique. 6. The results indicate that eliprodil, under normal conditions, moderately lengthens cardiac repolarisation by inhibition of I(Kr). However, after the attenuation of the normal 'repolarisation reserve', this drug can induce marked QT interval prolongation, which may result in proarrhythmic action.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/15302678-10533566, http://linkedlifedata.com/resource/pubmed/commentcorrection/15302678-10675203, http://linkedlifedata.com/resource/pubmed/commentcorrection/15302678-10853872, http://linkedlifedata.com/resource/pubmed/commentcorrection/15302678-10860023, http://linkedlifedata.com/resource/pubmed/commentcorrection/15302678-11271945, http://linkedlifedata.com/resource/pubmed/commentcorrection/15302678-11283229, http://linkedlifedata.com/resource/pubmed/commentcorrection/15302678-11336111, http://linkedlifedata.com/resource/pubmed/commentcorrection/15302678-11730974, http://linkedlifedata.com/resource/pubmed/commentcorrection/15302678-12154275, http://linkedlifedata.com/resource/pubmed/commentcorrection/15302678-12237256, http://linkedlifedata.com/resource/pubmed/commentcorrection/15302678-12422144, http://linkedlifedata.com/resource/pubmed/commentcorrection/15302678-12849400, http://linkedlifedata.com/resource/pubmed/commentcorrection/15302678-5485144, http://linkedlifedata.com/resource/pubmed/commentcorrection/15302678-7723350, http://linkedlifedata.com/resource/pubmed/commentcorrection/15302678-7860924, http://linkedlifedata.com/resource/pubmed/commentcorrection/15302678-8313427, http://linkedlifedata.com/resource/pubmed/commentcorrection/15302678-8330380, http://linkedlifedata.com/resource/pubmed/commentcorrection/15302678-8330381, http://linkedlifedata.com/resource/pubmed/commentcorrection/15302678-8575070, http://linkedlifedata.com/resource/pubmed/commentcorrection/15302678-8691967, http://linkedlifedata.com/resource/pubmed/commentcorrection/15302678-8719234, http://linkedlifedata.com/resource/pubmed/commentcorrection/15302678-8873679, http://linkedlifedata.com/resource/pubmed/commentcorrection/15302678-8962574, http://linkedlifedata.com/resource/pubmed/commentcorrection/15302678-9004957, http://linkedlifedata.com/resource/pubmed/commentcorrection/15302678-9205959, http://linkedlifedata.com/resource/pubmed/commentcorrection/15302678-9268220, http://linkedlifedata.com/resource/pubmed/commentcorrection/15302678-9519265, http://linkedlifedata.com/resource/pubmed/commentcorrection/15302678-9614489, http://linkedlifedata.com/resource/pubmed/commentcorrection/15302678-9708480
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0007-1188
pubmed:author
pubmed:issnType
Print
pubmed:volume
143
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
152-8
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:15302678-Action Potentials, pubmed-meshheading:15302678-Animals, pubmed-meshheading:15302678-Arrhythmias, Cardiac, pubmed-meshheading:15302678-Barium Compounds, pubmed-meshheading:15302678-Chlorides, pubmed-meshheading:15302678-Dogs, pubmed-meshheading:15302678-Electrocardiography, pubmed-meshheading:15302678-Electrophysiology, pubmed-meshheading:15302678-Female, pubmed-meshheading:15302678-Heart, pubmed-meshheading:15302678-Male, pubmed-meshheading:15302678-Membrane Potentials, pubmed-meshheading:15302678-Microelectrodes, pubmed-meshheading:15302678-Neuroprotective Agents, pubmed-meshheading:15302678-Papillary Muscles, pubmed-meshheading:15302678-Patch-Clamp Techniques, pubmed-meshheading:15302678-Piperidines, pubmed-meshheading:15302678-Potassium Channel Blockers, pubmed-meshheading:15302678-Potassium Channels, Inwardly Rectifying, pubmed-meshheading:15302678-Rabbits
pubmed:year
2004
pubmed:articleTitle
Effect of a neuroprotective drug, eliprodil on cardiac repolarisation: importance of the decreased repolarisation reserve in the development of proarrhythmic risk.
pubmed:affiliation
Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, University of Szeged, Dóm tér 12, PO Box 427, Szeged H-6701, Hungary.
pubmed:publicationType
Journal Article, In Vitro, Research Support, Non-U.S. Gov't